AMG 910

· Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG 910, covering 2024-01-25 to 2024-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 1]

See pricing